Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS ... colleagues report that they have identified a key pathway that sets off neurodegeneration in the early ...

ALS, or amyotrophic lateral sclerosis, is a devastating neurodegenerative disease ... “We saw that an important signaling pathway – the sonic hedgehog (Shh) signaling pathway – was disrupted. This ...

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Amyotrophic Lateral Sclerosis [ALS] is a type of disorder ... there is still a chance for this program to have a pathway forward. How so? Well, the reason is that the company still has to do ...

Repeated brain injury resulted in SOD1-ALS mice showing greater weight loss, an earlier tremor in the hind limbs, and ...

Amyotrophic lateral sclerosis ("ALS") is an incurable neurodegenerative disease that causes complete paralysis and death within 2-5 years from diagnosis. Every year, more than 5,000 people are ...

including amyotrophic lateral sclerosis ("ALS") and multiple sclerosis ("MS"). The company recently secured a new $10 million debt facility, which enables the payoff of another higher interest ...